What potential genetic therapies are being explored for ADHD?

PostedAugust 19, 2025

UpdatedSeptember 4, 2025

ByMy Patient Advice

Author: Lucia Alvarez, MSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

ADHD genetic therapies are at the forefront of research, offering potential breakthroughs in how ADHD is treated. Advances in gene therapy and treatment innovation are exploring ways to target the genetic factors that contribute to ADHD, aiming for solutions that go beyond traditional methods.

By studying ADHD DNA, scientists are identifying specific genes that influence the condition, particularly those related to dopamine regulation. These insights are paving the way for therapies that could modify the genetic components that cause ADHD, offering more lasting and targeted treatments.

Key Approaches in Genetic Therapy for ADHD

Gene Therapy

Gene therapy is an emerging field that looks at directly altering genes responsible for ADHD. By focusing on genes involved in dopamine regulation, this approach aims to address the root causes of ADHD.
Although still in the early stages, gene therapy offers exciting possibilities for long-term solutions.

Pharmacogenetics

Using pharmacogenetics, treatments can be personalised based on an individual’s genetic profile. This method looks at how variations in ADHD DNA affect the body’s response to medications, allowing for more effective, tailored treatment plans.
As treatment innovation continues to evolve, pharmacogenetics could revolutionise ADHD care by providing customised solutions.

The potential of ADHD genetic therapies continues to grow. Visit providers like ADHD Certify nfor care that integrates the latest in genetic insights and contemporary treatment strategies.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Genetic Factors in ADHD.

Lucia Alvarez, MSc

Author

Lucia Alvarez is a clinical psychologist with a Master’s in Clinical Psychology and extensive experience providing evidence-based therapy and psychological assessment to children, adolescents, and adults. Skilled in CBT, DBT, and other therapeutic interventions, she has worked in hospital, community, and residential care settings. Her expertise includes grief counseling, anxiety management, and resilience-building, with a strong focus on creating safe, supportive environments to improve mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.